PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jrsocmedLink to Publisher's site
 
J R Soc Med. 1983 June; 76(6): 452–457.
PMCID: PMC1439214

Effect of different corticosteroid regimens on hypothalamic-pituitary-adrenal axis and growth in juvenile chronic arthritis.

Abstract

Linear growth was recorded in 36 children with juvenile chronic arthritis. In 20, the hypothalamic-pituitary-adrenal axis (HPA axis) was assessed by insulin-induced hypoglycaemia, the results of which correlated well with resting cortisol levels. Three groups were identified according to type of corticosteroid regimen administered. Group 1 (6 children), receiving daily corticosteroid therapy, were clearly suppressed and failing to grow. Group 2 (13 children) had received an alternate-day regimen from the initiation of corticosteroid therapy; they were not suppressed and growth was satisfactory in 11. Group 3 (17 children) were receiving alternate-day therapy, but had had daily corticosteroid in the past; they showed no clear pattern of suppression or growth. Factors influencing the recovery of the HPA axis and resumption of growth were assessed. No difference was found in the individual growth of 7 children who commenced alternate-day therapy before the age of 5, compared with matched controls. It is suggested that daily divided doses of corticosteroid should not be used. Ideally, a single morning dose (up to 2 mg/kg) alternate-day regimen should be employed, as this regimen has minimal effects on HPA function and growth, even in young children. For very severe systemic features, it may be necessary to add a small single dose on the alternate day.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (658K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Ansell BM, Bywaters EG. Alternate-day corticosteroid therapy in juvenile chronic polyarthritis. J Rheumatol. 1974 Jun;1(2):176–186. [PubMed]
  • Axelrod L. Glucocorticoid therapy. Medicine (Baltimore) 1976 Jan;55(1):39–65. [PubMed]
  • Bacon GE, Spencer ML. Pediatric uses of steroids. Med Clin North Am. 1973 Sep;57(5):1265–1276. [PubMed]
  • BLODGETT FM, BURGIN L, IEZZONI D, GRIBETZ D, TALBOT NB. Effects of prolonged cortisone therapy on the statural growth, skeletal maturation and metabolic status of children. N Engl J Med. 1956 Apr 5;254(14):636–641. [PubMed]
  • Elders MJ, Wingfield BS, McNatt ML, Clarke JS, Hughes ER. Glucocorticoid therapy in children. Effect on somatomedin secretion. Am J Dis Child. 1975 Dec;129(12):1393–1396. [PubMed]
  • Elsasser U, Wilkins B, Hesp R, Thurnham DI, Reeve J, Ansell BM. Bone rarefaction and crush fractures in juvenile chronic arthritis. Arch Dis Child. 1982 May;57(5):377–380. [PMC free article] [PubMed]
  • Fauci AS. Alternate-day corticosteroid therapy. Am J Med. 1978 May;64(5):729–731. [PubMed]
  • HARTER JG, REDDY WJ, THORN GW. STUDIES ON AN INTERMITTENT CORTICOSTEROID DOSAGE REGIMEN. N Engl J Med. 1963 Sep 19;269:591–596. [PubMed]
  • Kuzemko JA, Lines JG. Adrenal cortical function in asthmatic children on alternate day steroids. Arch Dis Child. 1971 Jun;46(247):366–370. [PMC free article] [PubMed]
  • Loeb JN. Corticosteroids and growth. N Engl J Med. 1976 Sep 2;295(10):547–552. [PubMed]
  • MacGregor RR, Sheagren JN, Lipsett MB, Wolff SM. Alternate-day prednisone therapy. Evaluation of delayed hypersensitivity responses, control of disease and steroid side effects. N Engl J Med. 1969 Jun 26;280(26):1427–1431. [PubMed]
  • MATTINGLY D, DENNIS PM, PEARSON J, COPE CL. RAPID SCREENING TEST FOR ADRENAL CORTICAL FUNCTION. Lancet. 1964 Nov 14;2(7368):1046–1049. [PubMed]
  • Morris HG, Jorgensen JR, Elrick H, Goldsmith RE. Metabolic effects of human growth hormone in corticosteroid-treated children. J Clin Invest. 1968 Mar;47(3):436–451. [PMC free article] [PubMed]
  • Soyka LF. Treatment of the nephrotic syndrome in childhood. Use of an alternate-day prednisone regimen. Am J Dis Child. 1967 Jun;113(6):693–701. [PubMed]
  • Sturge RA, Beardwell C, Hartog M, Wright D, Ansell BM. Cortisol and growth hormone secretion in relation to linear growth: patients with Still's disease on different therapeutic regimens. Br Med J. 1970 Sep 5;3(5722):547–551. [PMC free article] [PubMed]
  • Tanner JM, Goldstein H, Whitehouse RH. Standards for children's height at ages 2-9 years allowing for heights of parents. Arch Dis Child. 1970 Dec;45(244):755–762. [PMC free article] [PubMed]
  • Tanner JM, Whitehouse RH, Takaishi M. Standards from birth to maturity for height, weight, height velocity, and weight velocity: British children, 1965. II. Arch Dis Child. 1966 Dec;41(220):613–635. [PMC free article] [PubMed]
  • Ward DJ, Hartog M, Ansell BM. Corticosteroid-induced dwarfism in Still's disease treated with human growth hormone. Clinical and metabolic effects including hydroxyproline excretion in two cases. Ann Rheum Dis. 1966 Sep;25(5):416–421. [PMC free article] [PubMed]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press